The Senate Judiciary Committee is scheduled to consider two bills Thursday that would effectively nullify the Supreme Court's ...

The Avanci Patent Pool, which the suit said includes Panasonic, represents 60 or more companies with patents in the 4G and 5G ...

raise the cost of medicines. The problem cited by the lawmakers concerns the way that administrative delays are handled at ...

AAM, The ERISA Industry Committee and Transparency-Rx sent a letter to Congressional leaders urging prompt legislative action ...

Gevo (GEVO) surges after receiving US patent for ethanol-to-olefins process, aiming to improve energy efficiency and reduce ...

In late June, generic drug maker Teva Pharmaceuticals launched a generic version of Victoza, a blockbuster diabetes drug, in ...

A federal court jury in Texas has awarded more than $30 million in damages to woman-owned beauty start-up Lashify Inc. The ...

Drug shortages are becoming increasingly common. Shortages have been observed across a range of therapeutic areas, ...

A system revision in Japan in October will increase out-of-pocket expenses for patients who choose the original version of ...

Gevo has been awarded U.S. Patent No. 12,043,587 B2 covering the ETO process. This patent protects the process of using certain proprietary catalyst combinations for converting ethanol into olefins.

On August 6, 2024, the China National Intellectual Property Administration (CNIPA) announced the fee standards for patent term adjustment ...